openPR Logo
Press release

Automated External Defibrillators (AEDs) Market will double by 2034, reaching USD 2.86 billion at a 7.1% CAGR

07-30-2025 12:21 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Automated External Defibrillators (AEDs)

Automated External Defibrillators (AEDs)

Automated External Defibrillators (AEDs) are revolutionizing how sudden cardiac arrest (SCA) is managed across healthcare and public settings. With cardiovascular diseases claiming millions of lives annually, AEDs offer a crucial intervention that can significantly increase survival rates. As governments mandate AED deployment in public areas and as healthcare providers push for better emergency response systems, the AED market is expected to witness robust growth in the coming decade.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68129

According to Exactitude Consultancy, the Automated External Defibrillators (AEDs) Market was valued at USD 1.45 billion in 2024 and is projected to reach USD 2.86 billion by 2034, growing at a CAGR of 7.1% from 2024 to 2034. This growth reflects increasing global concern for cardiac health, technological advances in defibrillator design, and policy-driven initiatives for public safety.

Market Overview: Key Highlights
• Market Size (2024): USD 1.45 Billion
• Forecast Size (2034): USD 2.86 Billion
• CAGR (2024-2034): 7.1%
• Key Drivers: Rising SCA cases, public access AED programs, technological integration (Wi-Fi, real-time monitoring)
• Challenges: High costs in low-income regions, lack of trained responders, regulatory variations
• Leading Players: ZOLL Medical Corporation, Philips Healthcare, Stryker, Mediana, Nihon Kohden, Cardiac Science, Schiller AG

Segmentation Analysis
By Type:
• Fully Automated AEDs
• Semi-Automated AEDs

By Technology:
• Wearable AEDs
• Portable AEDs

By End Use:
• Hospitals & Clinics
• Public Access Settings (Airports, Malls, Schools)
• Homecare
• Emergency Medical Services (EMS)

By Application:
• Sudden Cardiac Arrest
• Ventricular Fibrillation
• Other Arrhythmias

Summary:
The AED market segmentation reflects its adaptability across both medical and non-medical settings. Semi-automated AEDs dominate due to their balance of user guidance and manual control, while public access installations continue to grow, especially in developed countries. Technological advancements like wearable AEDs are opening new frontiers in personal cardiac safety.

Explore Full Report here: https://exactitudeconsultancy.com/reports/68129/automated-external-defibrillators-aeds-market

Regional Analysis
North America:
• Leading region due to strong public health infrastructure and widespread awareness campaigns.
• The U.S. accounts for the largest share with mandated AED installation in federal buildings and schools.
Europe:
• Significant growth led by the UK, Germany, and France.
• EU health policies encourage AED placement in crowded public zones.
Asia-Pacific:
• Fastest-growing region, driven by improving healthcare access in China, India, and Japan.
• Japan shows mature deployment; India and ASEAN are emerging rapidly.
Middle East & Africa:
• Steady uptake in Gulf Cooperation Council (GCC) countries.
• Limited penetration in Africa due to healthcare infrastructure gaps.
Latin America:
• Brazil and Mexico are investing in emergency medical response systems, slowly increasing AED adoption.

Summary:
While North America and Europe dominate in current deployment, Asia-Pacific is expected to register the highest CAGR due to growing awareness and government initiatives in urban health reform. Regional dynamics show that affordability, training, and infrastructure heavily influence AED adoption.

Market Dynamics
Key Growth Drivers:
• Rising SCA Incidence: With over 350,000 out-of-hospital cardiac arrests occurring annually in the U.S. alone, the urgency for AEDs is clear.
• Government Regulations & Funding: Several countries now mandate AEDs in transport hubs, stadiums, and schools.
• Technological Integration: Modern AEDs feature GPS, voice-guided operation, connectivity, and automated reporting, making them accessible to untrained users.
• Corporate and Institutional Adoption: AEDs are becoming common in offices, gyms, and universities due to workplace safety mandates.

Key Challenges:
• Cost Barriers in Low-income Regions: AEDs are expensive for developing countries and rural zones without external funding.
• Training Gaps: AEDs require basic knowledge for effective use-insufficient training limits life-saving potential.
• Device Maintenance and Battery Life: Regular maintenance is critical, but often overlooked in public settings.

Latest Trends:
• Smart AEDs: Integration with mobile apps and cloud platforms for real-time status tracking and remote monitoring.
• Miniaturization & Portability: Lightweight, wearable AEDs designed for athletes and at-risk individuals.
• AI in Emergency Response: Some new models include AI-driven analysis to improve rhythm detection accuracy.
• Defibrillator Sharing Programs: Community models where AEDs are shared and tracked across neighborhoods.

Get Your Exclusive Offer with up to 10% Discount :https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=68129

Competitor Analysis
Major Players in the Market:
1. ZOLL Medical Corporation - Leader in EMS-grade AEDs; ResQ Series popular among hospitals.
2. Philips Healthcare - Known for HeartStart Series; strong global footprint.
3. Stryker - LifePak series caters to both hospitals and field responders.
4. Nihon Kohden Corporation - Focuses on high-accuracy rhythm detection; expanding in Asia.
5. Schiller AG - Strong European presence; known for portability innovations.
6. Mediana - Competitive pricing model; focuses on emerging economies.
7. Cardiac Science Corporation - Powerheart AED series; acquired by ZOLL, strengthening its reach.
8. CU Medical Systems - Growing global presence; user-friendly designs.
9. Defibtech, LLC - AEDs with high battery life; known for school and public sector use.
10. Bexen Cardio - Spanish company with key deployments across EU institutions.

Summary:
The AED market is moderately consolidated, with top players focusing on smart, portable, and easy-to-use devices. Strategic partnerships with government bodies, hospitals, and sports organizations remain a key competitive approach. M&A activities, such as ZOLL's acquisition of Cardiac Science, highlight ongoing efforts to expand product portfolios and market share.

Conclusion: A Market That Saves Lives and Grows Steadily
The global Automated External Defibrillators market is more than just a healthcare equipment sector-it's a crucial contributor to saving lives. As sudden cardiac arrest remains one of the top causes of death worldwide, public and private sector collaboration is pushing AED accessibility to the forefront.

With a CAGR of 7.1% and market size projected to nearly double by 2034, the future holds significant opportunities. Demand is being fueled by policy mandates, technological breakthroughs, and rising public awareness. However, to unlock its full potential, the industry must address challenges like affordability and user training, especially in emerging regions.

Key Takeaways:
• AEDs are vital in emergency cardiac care and public safety.
• North America leads, but Asia-Pacific is the future growth engine.
• Smart and wearable AEDs are shaping next-gen devices.
• Strategic partnerships and innovation are critical for market expansion.
As healthcare continues to shift toward preventive and community-based solutions, AEDs will play an indispensable role in shaping a safer, healthier future.

This report is also available in the following languages : Japanese (自動体外除細動器(AED)市場), Korean (자동 체외 제세동기(AED) 시장), Chinese (自动体外除颤器(AED)市场), French (Marché des défibrillateurs externes automatisés (DEA)), German (Markt für automatisierte externe Defibrillatoren (AEDs)), and Italian (Mercato dei defibrillatori automatici esterni (DAE)), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/68129/automated-external-defibrillators-aeds-market#request-a-sample

Our More Reports:

Logistics and Cold Chain Market
https://exactitudeconsultancy.com/reports/67865/logistics-and-cold-chain-market

LDS Antenna Market
https://exactitudeconsultancy.com/reports/67863/lds-antenna-market

Nano Gas Sensor Market
https://exactitudeconsultancy.com/reports/67861/nano-gas-sensor-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Automated External Defibrillators (AEDs) Market will double by 2034, reaching USD 2.86 billion at a 7.1% CAGR here

News-ID: 4126286 • Views:

More Releases from Exactitude Consultancy

Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at 8.1% CAGR
Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at …
Introduction Hypertrophic cardiomyopathy (HCM) is a genetic heart disorder characterized by abnormal thickening of the heart muscle, which can impair blood flow and increase the risk of arrhythmias, heart failure, and sudden cardiac death. Once managed primarily through beta-blockers, calcium channel blockers, and invasive procedures, the HCM treatment landscape has expanded with the approval of targeted therapies such as cardiac myosin inhibitors. Growing awareness of genetic cardiovascular diseases, advances in molecular diagnostics,
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion by 2034, Growing at 10.3% CAGR
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion …
Introduction Biologics-including monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies-are at the forefront of modern medicine. Their development, however, requires significant expertise, advanced infrastructure, and compliance with stringent regulatory standards. To meet these demands, pharmaceutical and biotechnology companies are increasingly outsourcing to Contract Research Organizations (CROs) specializing in biologics. Biologics CROs provide services spanning discovery, preclinical research, clinical trials, bioanalytical testing, and regulatory consulting. With the rise of biologics, biosimilars, and advanced
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% CAGR
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% …
Introduction Niemann-Pick disease (NPD) is a group of rare, inherited lysosomal storage disorders caused by mutations that disrupt lipid metabolism, leading to progressive neurological decline, organ dysfunction, and premature death. The condition is categorized into several subtypes (A, B, and C), each varying in severity and progression. Historically, treatment has been limited to palliative and supportive care. However, the landscape is changing rapidly with the development of enzyme replacement therapies (ERT), substrate
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: Novartis AG & GSK
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: N …
The fight against cancer and neurodegenerative diseases has brought the spotlight on the PERK (Protein kinase RNA-like endoplasmic reticulum kinase) pathway, a critical regulator of the unfolded protein response. PERK inhibitors are designed to modulate this pathway, reducing stress-induced cell death and playing a pivotal role in oncology, neurodegenerative research, and metabolic disorders. As precision medicine continues to gain traction, PERK inhibitors are attracting significant attention from both biotech firms

All 5 Releases


More Releases for AED

NKN MEDIA RAISES AED 35 MILLION, PLANS TO RAISE ANOTHER AED 50 MILLION FOR AGGRE …
NKN Media, a leading integrated media powerhouse, has successfully raised AED 35 million and is all set to raise another AED 50 million to accelerate its global expansion and develop IPs. Celebrating five years in Dubai, NKN Media has further cemented its position as a key player in the region's media and events landscape. Following the resounding success of the Dubai Property Expo, which saw strong engagement in Singapore, the company
10-21-2024 | Health & Medicine
Getnews
AEDLAND: Offering Accessible and Affordable AED Supplies
Know more about the importance of having extra AED batteries People purchase Automated External Defibrillators (AEDs) for several reasons. Primarily, it is a vital tool for saving lives. In cases of sudden cardiac arrest, immediate defibrillation can significantly increase the chances of survival. AEDs are also becoming more accessible and affordable, making them a practical investment for individuals, businesses, and communities. AEDLAND is a trusted machine distributor and they also offer
Extended Reality at AED Studios in Belgium
Starting in September, AED Studios in Lint (Belgium) will offer TV, film and event producers the opportunity to use a high-tech XR studio. Extended reality (XR) is the umbrella term for virtual reality (VR), augmented reality (AR), mixed reality (MR) and other immersive technologies. At the XR studio, the physical and digital worlds are perfectly connected, allowing for new, expanded and unique possibilities for audiovisual productions. The XR Studio is
World First in Air Disinfection at AED Studios
Willebroek, Belgium, Jul 01, 2020 -- Glenn Roggeman, CEO of AED Group, launched the first UVC luminaires under the AED private label Luxibel as early as April. The system was further developed for larger spaces with an audience where air circulation needs to be taken into account. Roggeman used his knowledge of aerodynamics that he gained during his training as a helicopter pilot. 'The main advantage of this system is
Dunkin’ Donuts Raises Aed 40,000 For Children’s Charity
Gesture in support of Sharjah City for Humanitarian Services Special Needs Kids As part of its ongoing commitment to community welfare and to extend a helping hand to the differently-abled, Dunkin’ Donuts recently presented a cheque for AED 40,000 to the Sharjah City for Humanitarian Services (SCHS) – a charity set up to support children with special needs. The amount was raised through a special promotion organised by the coffee
AED Brands Introduces a Free AED Resource Center
AED Brands, an authorized automated external defibrillator dealer, today announced their newest web site addition, the AED Resource Center. This free resource for AED information contains five sections of AED facts and knowledge that will help educate and inform lay people and medical professionals alike about automated external defibrillators and their importance in treating sudden cardiac arrest (SCA). The five sections in the AED Resource Center are: • AED Market Guides • Recent AED